Cynthia Pussinen
Chief Executive Officer at SERNOVA CORP.
Net worth: - $ as of 2024-03-30
Profile
Cynthia Pussinen is currently the Chief Executive Officer & Director at Sernova Corp.
Prior to her current position, she served as the Chief Technical Officer at Spark Therapeutics, Inc. from 2021 to 2022.
She also held the position of Executive Vice President-Technical Development at Actinium Pharmaceuticals, Inc. Ms. Pussinen holds a graduate degree from Rensselaer Polytechnic Institute and an undergraduate degree from the University of Connecticut.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SERNOVA CORP.
-.--% | 2023-09-04 | 0 ( -.--% ) | - $ | 2024-03-30 |
Cynthia Pussinen active positions
| Companies | Position | Start |
|---|---|---|
| SERNOVA CORP. | Chief Executive Officer | 2023-09-04 |
Former positions of Cynthia Pussinen
| Companies | Position | End |
|---|---|---|
| SPARK THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2022-11-30 |
| ACTINIUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Training of Cynthia Pussinen
| Rensselaer Polytechnic Institute | Graduate Degree |
| University of Connecticut | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| SERNOVA CORP. | Health Technology |
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
- Stock Market
- Insiders
- Cynthia Pussinen
